                                                                      Human Molecular Genetics, 2013, Vol. 22,  24               4967–4977
                                                                      doi:10.1093/hmg/ddt344
                                                                      Advance Access published July 19, 2013


MYBPC1 mutations impair skeletal muscle function zebrafish models arthrogryposis
Kyungsoo Ha1, Jillian G. Buchan2, David M. Alvarado1, Kevin Mccall1, Anupama Vydyanath4,
Pradeep K. Luther4, Matthew  Goldsmith3, Matthew B. Dobbs1,5 Christina  Gurnett1,2,3,∗
1
 Department Orthopaedic Surgery, 2Department Neurology 3Department Pediatrics, Washington University
School Medicine, St. Louis, MO, USA, 4Heart Lung Institute, Imperial College, London, UK 5St. Louis Shriners
Hospital Children, St. Louis, MO, USA

Received April 22, 2013; Revised July 9, 2013; Accepted July 16, 2013


Myosin-binding protein C1 (MYBPC1) abundant skeletal muscle protein expressed predominantly slow-twitch muscle fibers. Human MYBPC1 mutations associated distal arthrogryposis type 1 lethal
congenital contracture syndrome type 4. MYBPC1 function incompletely understood, mechanism human mutations result contractures unknown.  demonstrate using antisense morpholino
knockdown, mybpc1 required embryonic motor activity survival zebrafish model arthrogry-
posis. Mybpc1 morphant embryos severe body curvature, cardiac edema, impaired motor excitation delayed hatching. Myofibril organization selectively impaired slow skeletal muscle sarcomere
numbers greatly reduced mybpc1 knockdown embryos, electron microscopy reveals normal
sarcomere structure. evaluate effects human distal arthrogryposis mutations, mybpc1 mRNAs contain-
ing corresponding human W236R Y856H MYBPC1 mutations injected embryos. Dominant-
negative effects mutations suggested resultant mild bent body curvature, decreased
motor activity, impaired overall survival compared overexpression wild-type RNA. results demonstrate critical role mybpc1 slow skeletal muscle development establish zebrafish tractable model human distal arthrogryposis.




INTRODUCTION                                                              distal arthrogryposis, remarkably studies addressed
                                                                          mechanism mutations cause limb contractures.
Distal arthrogryposis syndromes group autosomal dom-                 Genes encoding myosin-binding protein C belong intra-
inant disorders characterized non-progressive congenital               cellular immunoglobulin superfamily abundantly
contractures distal limbs (1). different distal arthro-        expressed muscle (9). genes encode myosin-binding
gryposis syndromes described date, including                 protein C proteins human mouse genomes distal arthrogryposis type 1 affects 10 000          expressed predominantly slow skeletal muscle (MYBPC1),
individuals (2). Patients distal arthrogryposis type 1          fast skeletal muscle (MYBPC2) cardiac muscle (MYBPC3)
contractures limited hands feet (1).              (10,11). Cardiac MYBPC3 mutations described majority genes implicated distal arthrogryposis                 1995 considered common causes
pathogenesis far encode components sarcomere               human hypertrophic cardiomyopathy (12,13). recently,
contractile apparatus myofibers, including b-tropomyosin               mutations slow skeletal muscle MYBPC1 gene iden-
(TPM2), troponin type 2 (TNNI2), troponin T type 3 (TNNT3),             tified families autosomal dominant distal arthrogry-
myosin heavy chain 3 (MYH3) (3–6) myosin-binding                      posis type 1 phenotype includes severe congenital
protein C1 (MYBPC1) (7). Mutations genes               clubfoot, vertical talus camptodactyly (7). human 40  distal arthrogryposis patients (8). Despite fre-       MYBPC1 W236R Y856H mutations located quency sarcomeric gene mutations identified          myosin-binding protein C unique motif (M-motif) 
∗ correspondence addressed  Department Neurology, Washington University School Medicine, 660 S Euclid Avenue, St. Louis,
MO 63110, USA. Tel: +1 314 286 2789; Fax: +1 314 286 2894; Email: gurnettc@neuro.wustl.edu

# Author 2013. Published Oxford University Press. rights reserved. Permissions, email: journals.permissions@oup.com
4968      Human Molecular Genetics, 2013, Vol. 22,  24


C-terminal C8 domain, respectively (7). Exogenous expression          mobility. mutations responsible distal arthro- MYBPC1 containing mutations murine muscle                 gryposis predicted cause disease dominant-negative
demonstrated correct sarcomeric localization MYBPC1                mechanism, functional motor activity assay used mutant proteins (7), functional effects muta-     evaluate MYBPC1 gene mutations relevant variety
tions evaluated. recent report described homozy-      additional human disease genes.
gous MYBPC1 nonsense mutations unrelated Bedoin
families autosomal recessive lethal congenital contracture
syndrome type 4 (14).                                                 RESULTS
   myosin-binding protein C family proteins plays              Localization mybpc1 slow-twitch skeletal
important structural regulatory roles muscle function          muscle sarcomere
(reviewed 15). provide filament stability interacting titin rod portion sarcomeric myosin (light            zebrafish genome contains single mybpc1 ortholog meromyosin) C-terminal region (16,17). myosin-        chromosome 4 68.9  nucleotide identity human
binding protein C unique M-motif modulates contractility      MYBPC1. Mybpc1 transcripts detected early 9 h
dynamic interactions head region (S2) myosin          postfertilization (hpf), present somite development
actin (18–20). Critical residues M-motif          myogenic differentiation 12 24 hpf phosphorylated PKA PKC (21), presenting additional          abundant 24 72 hpf (Fig. 1A). 
mechanism myosin-binding protein C regulate              mount immunofluorescence using anti-Mybpc1 antibody
contractility (22,23). addition structural functions,     demonstrated sarcomeric localization zebrafish embryo skel-
myosin-binding protein C1 interacts muscle-type creat-      etal muscles (Fig. 1B). skeletal muscle, mybpc1 ine kinase, potentially allowing regulate energy homeostasis    uniquely expressed superficial slow-twitch axial muscles muscle contraction coupling myofibril (22).          embryonic stages analyzed, consistent previously
   MYBPC3 mutations extensively studied            published situ data (28). Expression overlaps entirely role human hypertrophic cardiomyopathy (reviewed         slow-twitch myosin detected F59 antibody (29). 24,25), research MYBPC1 mutations limited.         Mybpc1 protein localized C-zone skeletal muscle
lines evidence suggest mechanism muta-           fibers observed characteristic doublet pattern
tions MYBPC1 MYBPC3 cause disease                  (Fig. 1C).
different.  MYBPC3 mutations consist predominantly nonsense mutations predicted cause autosomal dom-
inant hypertrophic cardiomyopathy haploinsufficiency          Mybpc1 knockdown results severe ventral body curvature
(25– 27), MYBPC3 missense mutations associated           determine mybpc1 required normal zebrafish devel- reduced MYBPC3 protein levels (26). contrast,        opment, employed antisense MOs achieve knockdown mutations MYBPC1 described distal            mybpc1 gene function. Splice-site translation start
arthrogryposis type 1, autosomal dominantly inherited        site blocking MOs injected 1- 4-cell-stage
missense mutations (7). MYPBC1 nonsense mutations               embryos. effectiveness mybpc1 MO downregulate described autosomal recessive lethal congenital          Mybpc1 protein expression verified western blotting.
contracture syndrome 4 (LCCS4), evidence              Mybpc1 morpholino reduced Mybpc1 protein expression level
muscle disease heterozygote carriers (14). Secondly, vivo       embryos 1 2 days postfertilization (dpf) (Fig. 2A).
experiments demonstrate single amino acid substitutions             Embryos injected 1 ng mybpc1 MO exhibited MYBPC3 cause protein fail incorporate           mild ventral body curvature 2 dpf (data shown), injec-
sarcomere, single amino acid substitutions                 tion 2 ng MOs resulted similar severe ventral
MYBPC1 localize properly (7). Despite correct localiza-         body curvature (n ¼ 280; Fig. 2B). MOs resulted
tion,  mechanisms MYBPC1 mutations               identical phenotypes, subsequent experiments
cause limb contractures characteristic distal arthrogrypo-     using splice-site MO. confirm pheno-
sis unknown. Genetic studies knockouts           type observed mybpc1 morphants consequence conducted animal model prior               mybpc1 deficiency, rescued mybpc1 morphants coinjec-
functional studies distal arthrogryposis sarcomeric gene           tion zebrafish mybpc1 mRNA sensitive mutations reports genetically based animal models        splice-site MO. Embryos injected mybpc1 mRNA
distal arthrogryposis, needed improve         revealed phenotypic changes compared control
understanding disorder.                                       embryos (data shown). injection mybpc1 MO zeb-
   study, demonstrate mybpc1 required     rafish mybpc1 mRNA resulted rescue ventrally curved development function slow skeletal muscle zebra-        phenotype 30  embryos (50 168 injected
fish. Antisense morpholino oligonucleotide (MO)-mediated              embryos) (Fig. 2B). Morphant embryos exhibited pericar-
depletion Mybpc1 expression results severe ventral body         dial edema poor growth eyes head (Fig. 2C). curvature, decreased motility early lethality,         mybpc1 morphants displayed massive cardiac edema impaired sarcomere development greatly reduced myofibril         associated reduced heart rate, particularly 3 dpf.
numbers. Furthermore, demonstrate human                  phenotypes observed embryos injected
MYBPC1 mutations exert dominant-negative effects                   control antisense MO.
muscle function expressed zebrafish development,             investigated presence chorion influ-
resulting embryo mild curvature impaired        ences ventrally curved phenotype mybpc1 morphants.
                                                                                         Human Molecular Genetics, 2013, Vol. 22,  24           4969


                                                                                      Mybpc1 morphants exhibited decreased survival rate com-
                                                                                      pared control embryos. .90  (72/80) control
                                                                                      MO-injected embryos survived 5 dpf, ,5  (6/174)                                                                                       mybpc1 morphant embryos survived 5 dpf, lived                                                                                       7 dpf, indicating mybpc1 knockdown embryonic lethal
                                                                                      (Fig. 3B).
                                                                                         zebrafish, recognizable skeletal muscle activity                                                                                       spontaneous embryo coiling flipping appears                                                                                       20 28 hpf (31) slow-twitch muscle activity
                                                                                      (32). frequency spontaneous body coiling reduced                                                                                       mybpc1 MO compared control MO-injected embryos                                                                                       24 hpf (8.32 + 0.33 versus 2.11 + 0.41, n ¼ 30, P , 0.0001).
                                                                                      Furthermore, body coiling weak mybpc1 MO,                                                                                       barely perceptible movements compared robust tail
                                                                                      movements seen control MO-injected embryos.
                                                                                         quantify differences early motor activity, mea-
                                                                                      sured photomotor response, stereotypic series motor
                                                                                      behaviors response high-intensity light stimulus (33).
                                                                                      Presentation light stimulus induces brief strong
                                                                                      motor excitation embryos resolves 5 s                                                                                       stimulus. Basal activity measured 3 s                                                                                       light stimulus. Using testing parameters, basal
                                                                                      motor activity photomotor responses reduced                                                                                       mybpc1 MO compared control MO-injected embryos
                                                                                      (Fig. 3C Supplementary Material, Videos S1 S2).
                                                                                      data suggest slow-twitch muscle function severely
                                                                                      affected reduction Mybpc1.
                                                                                         zebrafish escape response tactile stimulation motor
                                                                                      activity appears later development, 72 hpf.
                                                                                      Control MO-injected embryos respond tactile stimulus Figure 1. Localization mybpc1 slow skeletal muscle zebrafish control         rapid escape contraction. contrast, knockdown mybpc1
embryos.   RT-PCR analysis mybpc1 mRNA expression zebrafish 
trols embryos different times fertilization. Transcription mybpc1                                                                                       zebrafish embryos resulted loss touch sensitivity detectable 9 hpf. expression level EF1a served               evidence skeletal muscle contraction response phys-
loading control. (B) mount immunofluorescence staining anti-               ical stimulation (Fig. 3D).
Mybpc1 antibody zebrafish control embryos 1 dpf shows sarcomeric local-
ization. (C) Immunohistochemical staining transverse sections control
embryos anti-Mybpc1 antibody slow muscle myosin heavy chain anti-            Slow skeletal muscle myofibrils disorganized
body F59 zebrafish embryos 2 dpf. Inset shows characteristic doublet        mybpc1 morphant embryos
staining Mybpc1 C-zone sarcomere high power.
                                                                                      mybpc1 morphant movement severely impaired,
                                                                                      examined skeletal muscle evidence corre- examine  embryos dechorionated 8 hpf, 75                          sponding structural abnormalities. gross level, specification
epiboly, growth occur potential                         slow fast muscles appeared unaffected mybpc1 knock-
straint chorion. relatively straight body axis present                   assessed antibodies directed slow- (F59)
dechorionated control MO-injected embryos 1 dpf,                           fast-twitch (F310) muscle myosin heavy chains (Supplemen- mybpc1 morphants ventral body curvature 1 dpf                          tary Material, Fig. S1).  slow skeletal myofibers
gardless presence absence chorion curvature                    located superficial embryo trunk grossly disar-
remains development (Fig. 2D).  ventral                           rayed size number myofibrils greatly reduced
body curvature mybpc1 morphants independent                              mybpc1 morphant embryos (Fig. 4A). stark 
intact chorion.                                                                       trast organized slow skeletal muscles myofibers                                                                                       control embryos. Central nuclei present morphant
                                                                                      embryo slow muscle. Electron microscopy demonstrated
Defective motor activity mybpc1 morphants                                          disorganized myofibrils mybpc1 morphant embryos, examined effects mybpc1 knockdown motor                             individual sarcomere ultrastructure appeared relatively
activity zebrafish development. Embryos use muscular                           normal regularly aligned bands, bands, lines movements (e.g. flip tail) release                        M-lines (Fig. 4B Supplementary Material, Fig. S2). outer chorion. approximately 95  control                            provides evidence mybpc1 required normal devel-
MO-injected embryos hatched chorion 72 hpf,                          opment slow skeletal muscle myofibers, sarco-
expected wild-type (WT) embryos (30), 50                                 meres 
mybpc1-MO-injected embryos hatched stage                                define components skeletal muscle myofibril
sistent decrease overall muscle activity (Fig. 3A).                         affected mybpc1 knockdown, mount
4970       Human Molecular Genetics, 2013, Vol. 22,  24




Figure 2. Mybpc1 knockdown results severe ventral body curvature heart edema.   Mybpc1 protein expression significantly reduced mybpc1-MO-injected embryos 1 2 dpf compared control MO. (B) Morphology embryos injected control MO, mybpc1 splice-site MO mybpc1 translation MO 3 dpf. Injection mybpc1 MOs induced ventral body curvature embryos, coinjection mybpc1 mRNA resulted partial
rescue body curvature phenotype  panel). (C) Mybpc1 morphant embryos cardiac edema defect growth eyes head. (D) ventral
body curvature phenotype present mybpc1-MO embryos 1 3 dpf dechorionated 8 hpf.


immunofluorescence assays performed examine specific                    Morphological examinations heart mybpc1 morphant
components sarcomere. Immunostaining F59 revealed                   embryo
severely disrupted sarcomere formation filament organ-                Mybpc1 primarily slow-twitch skeletal
ization slow muscles mybpc1 morphant embryos compari-                  muscle, expressed human, rabbit, rat bovine
son controls (Fig. 4C D). sarcomeres                       hearts (34). Mybpc1 protein present zebrafish heart detected slow myofibers mybpc1 knockdown embryos.                      2 dpf detected anti-mybpc1-specific antibody (Supple-
contrast, organization fast muscle sarcomeres                    mentary Material, Fig. 3A). phenotype mybpc1 mor-
altered mybpc1 morphants shown staining fast                      phants included grossly apparent cardiac edema, low heart rate
muscle myosin-specific antibody F310 embryos 1 dpf                        cardiac enlargement misfolded, elongated morph-
(Fig. 4E F). determine mybpc1 loss affected organ-                ology (Supplementary Material, Fig. 3B).  sarcomeres
ization filaments slow muscle, immunostaining 
                                                                                appeared formed mybpc1 morphant heart demon-
formed using anti actin antibody. mybpc1 deficient
                                                                                strated mount immunostaining using F59 myosin
state, filaments stained anti actin antibody
                                                                                heavy chain antibody, suggesting mybpc1 required
showed poor organization little staining sarcomeric struc-
                                                                                filament assembly heart.
tures mybpc1-MO embryos compared control MO-
injected embryos (Fig. 4G H).
   understand role mybpc1 organization basic sarcomeric structures, analyzed localization                 Dominant-negative effects Mybpc1 mutant  M-line-specific proteins actinin myomesin,                  protein expression
respectively. Similar actin staining, sarcomeric locali-               previously showed MYBPC1 mutant proteins
zations actinin line myomesin M-line                      incorporate correctly sarcomeres (7), hypothesized present, markedly reduced, mybpc1 morphants                         human mutations cause disease (Fig. 4I –L).                                                                   gain function effects muscle function. Multiple
                                                                                   Human Molecular Genetics, 2013, Vol. 22,  24                   4971




Figure 3. Defective motor activity mybpc1 morphants.   Hatching delayed mybpc1-MO-injected embryos compared uninjected control
MO-injected embryos. (B) Survival curve showing reduced survival mybpc1 morphant embryos surviving past 5 dpf. (C) Photomotor response assay
demonstrating blunted motor response mybpc1-MO-injected embryos compared control MO-injected embryos 3-s light stimulus 30 hpf.
Data represent cumulative motor activity 10 embryos recorded single assay. (D) Touch-escape response demonstrates rapid escape response embryos injected control MO compared lack response mybpc1 morphants 3 dpf.


alignments revealed human DA1 MYBPC1 mutations                            40/129) Y845H (26 , n ¼ 33/124) mRNAs rarely
W236R Y856H highly conserved,  cor-                  observed control, WT mybpc1 embryos injected responding W220R Y845H mutations introduced                      H494Q mRNA corresponding human common polymorph- zebrafish mybpc1 sequence (Fig. 5A). negative control,                ism (Fig. 5B C). introduced zebrafish mybpc1 sequence mutation                      determine bent body phenotypes mutant
(H494Q), corresponds MYBPC1 H506Q human poly-                         embryos associated abnormal skeletal muscle myofiber
morphism (rs3817552) present overall minor allele                organization, performed filament immunostaining frequency 0.176. high frequency humans,                   muscle myosin heavy chains. Embryos injected H494Q mutation zebrafish Mybpc1 likely benign.                 W220R Y845H-mybpc1 mRNA showed slow muscle fibers
   Mutant mRNAs corresponding distal arthrogryposis                   undulated tightly compacted compared mutations injected zebrafish embryos order deter-              control uninjected WT-mybpc1 mRNA-injected embryos presence dominant-negative gain function                     (Fig. 5D). ultrastructural level, components sarco-
effects muscle activity. Overexpression WT-mybpc1                        mere appeared unchanged compared muscle control unin-
mRNA did result phenotype compared uninjected                  jected WT-mybpc1 RNA-injected embryos (Fig. 5E).
control embryos.  bent body phenotype observed                   Myofibers organized normal quantity. contrast 4 dpf embryos injected W220R (31 , n ¼                  structural changes seen slow-twitch muscle, fast skeletal
4972       Human Molecular Genetics, 2013, Vol. 22,  24




Figure 4. Mybpc1 morphant embryos myofibril disorganization slow skeletal muscle.   Reduced size number myofibrils observed mybpc1
morphants compared control embryos 2 dpf light microscopy. Central nuclei present. (B) Ultrastructural examination mybpc1 morphant slow muscle
shows disorganized myofibrils compared control embryos low power electron microscopy  images, scale bar equals 2 mm). Higher power images dem-
onstrate relatively normal appearing sarcomeres  images, scale bar equals 1 mm). (C–L) mount immunostaining control mybpc1 morphant
embryos slow muscle myosin filament (F59) (C D), fast muscle myosin filament (F310) (E F), filament actin (G H), line actinin  J) M-line myomesin (K L) 1 dpf. scale bars represent 20 mm.



muscle appeared morphologically normal embryos expressing                     RNA-injected embryos responded normally rapidly swimming
mutant protein assessed myosin heavy chain antibody                    field, W220R Y845H mutants consistently 4 dpf (Supplementary Material, Fig. S4).                                      moved body lengths touched (data shown).
   Overexpression human distal arthrogryposis mutant                     Embryos injected mybpc1 mutant W220R Y845H
mybpc1 mRNAs negatively affected embryonic motor activity                        mRNA failed survive past 10 dpf, suggesting embryonic development. Spontaneous body coiling                       motor deficits having significant effects overall sur-
frequency 24 hpf reduced W220R (6.45 + 0.61, n ¼                       vival (Fig. 5G). mild heart edema seen 60, P , 0.01) Y845H-mybpc1 (6.90 + 0.75, n ¼ 60, P ,                         mutant-injected embryos, embryos noted 0.01) RNA-injected embryos compared control uninjected                      severe heart edema reduced heart rates (data shown).
embryos (8.95 + 0.61, n ¼ 60). Likewise, hatching delayed embryos injected W220R (16 ; 11/65) Y845H-mybpc1 (16 ; 10/62) RNA compared control unin-
jected embryos (50 ; 44/88) 2 dpf, nearly embryos                DISCUSSION hatched 3 dpf.                                                           myosin-binding protein C discovered skeletal
   slow muscle activity quantified using photo-                muscle nearly 40 years ago, function remains poorly 
motor response 30 hpf, embryos injected W220R                 stood (9). results demonstrate slow skeletal Y845H-mybpc1 RNA demonstrated statistically significant                    muscle mybpc1 gene essential normal zebrafish embryonic
duction motor excitation compared control uninjected                 development. fact, mybpc1 morphant embryonic pheno-
WT-mybpc1 RNA-injected embryos (Fig. 5F Supplementary                        type remarkably similar recently
Material, Fig. S5).  reduced motor response                   described fetuses autosomal recessive lethal congenital
mybpc1 mutant RNA-injected embryos dramatic                        contractural syndrome type 4 (LCCS4) homozygous non- observed mybpc1-MO-injected embryos. expected,                        sense mutations MYBPC1 (14).
overexpression H494Q-mybpc1 variant corresponding                         demonstrate dominant-negative effects human
common human MYBPC1 gene polymorphism did                           distal arthrogryposis MYBPC1 missense mutations endogen-
effect zebrafish motor activity. Touch-escape response                    ous sarcomeric proteins. curved phenotype impaired mutant RNA-injected embryos compared                        penetrant severe seen mybpc1 morphants, WT-mybpc1 RNA-injected embryo assessed                          embryos overexpressing zebrafish mybpc1 W220R 3 dpf. control uninjected WT-mybpc1                              Y845H mutations (corresponding W236R Y856H
                                                                                     Human Molecular Genetics, 2013, Vol. 22,  24                    4973




Figure 5. Dominant-negative effects MYBPC1 human distal arthrogryposis mutations morphology motor function.   Location human distal arthro-
gryposis mutations W236R Y856H benign common polymorphism rs3817552 corresponding zebrafish mutations. Immunoglobulin domains shown circles fibronectin type III domains squares. (B) Percentage embryos bent body phenotype group embryos injected indicated mybpc1 mRNAs. Embryos injected W220R Y845H-mybpc1 showed highest frequency bent body phenotype. (C) Zebrafish overexpressing
W220R Y845H-mybpc1 mutations bent body phenotype 4 dpf. curve present control uninjected zebrafish, zebrafish overexpressing WT
mybpc1 mybpc1 containing common human polymorphism H494Q. (D) Abnormal slow muscle fiber organization W220R Y845H-mybpc1 mutant
embryos showing wavy myofibers increased distance fibers shown mount immunostaining antibody slow muscle myosin (F59) 4 dpf. (E) Sarcomere ultrastructure unchanged compared control uninjected WT-mybpc1 RNA overexpressing embryos evaluated electron
microscopy. (F) Embryos overexpressing W220R Y845H-mybpc1 decreased motor excitation response light stimulus compared control WT-mybpc1 overexpressing embryos measured mean motion index separate batches injected embryos. Embryos overexpressing H494Q-mybpc1 common human polymorphism similar photomotor response control uninjected WT-mybpc1 embryos (∗ P , 0.05; ∗∗ P , 0.01).
(G) Decreased survival embryos overexpressing W220R Y845H-mybpc1 assessed 7 dpf (∗ P , 0.01).


human MYBPC1 mutations) severe motor deficits                      potential functions needed determine mechanism consequence, decreased survival. previously observed                       distal arthrogryposis MYBPC1 mutations disrupt sarco-
normal sarcomeric localization mutant human MYBPC1                            meric function.
mutations (W236R Y856H) vivo (7), distal arthrogryposis                      contrast dominant-negative effects MYBPC1 muta-
mutations exert effects altering sarcomere stability              tions muscle function, vast majority MYBPC3 mutations
modifying skeletal muscle contractility interaction                  associated human hypertrophic cardiomyopathy cause sarcomeric proteins. Myosin-binding protein C inter-                  disease gene haploinsufficiency (25,36). acts directly light meromyosin, actin, titin myosin                 allelic series MYBPC1 mutations small make 
head region (S2) (reviewed 15), providing multiple poten-                   clusions range types mutations causing distal
tial interactions altered human mutations.                  arthrogryposis, MYBPC1 haploinsufficiency reported fact, Ackermann et al. recently reported                      cause muscle disease heterozygous parents relatives human distal arthrogryposis mutations alter ability recom-                fetuses lethal congenital contractural syndrome binant MYBPC1 fragments interact myosin actin                        homozygous MYBPC1 nonsense mutations (14). vitro, abolishing actomyosin regulatory properties                MYBPC1 mutations appear cause disease potentially
(35). studies directed investigating                    different mechanism MYBPC3 mutations, functional studies
4974      Human Molecular Genetics, 2013, Vol. 22,  24

 distal arthrogryposis hypertrophic cardiomyopathy          useful testing functional consequences human mutations
mutations likely provide complementary insights        robust motor phenotype. distal
unique properties proteins.                                    arthrogryposis-associated genes associated extensive
    presence cardiac edema, reduced heart rate, abnor-      genetic variation controls muscle disease (3),
mal heart looping mybpc1 morphant fish suggests       distinguishing normal variants pathogenic
mybpc1 necessary early heart development,          poses major challenge. mutations distal possible findings non-specific secondary   arthrogryposis-associated genes predicted cause
impaired mobility. early studies failed evidence      dominant-negative effects, quantitative assay Mybpc1 expression murine human heart (37), Mybpc1            used study functional effects variants
protein expression recently shown normal adult             currently classified unknown significance
mammalian heart (34).  demonstrate Mybpc1 protein              variety human disease genes.
expression early zebrafish cardiac development.           study addresses need tractable models human
ingly, lethal phenotype observed mybpc1 morphant            arthrogryposis demonstrates zebrafish effectively
fish lies contrast lack apparent early developmen-    model effects MYBPC1 mutations associated lethal
tal phenotype cardiac mybpc3 expression abolished          congenital contracture syndrome distal arthrogryposis. mice (38).  mybpc1 sufficient support normal            current findings provide evidence dominant-negative cardiac development absence mybpc3 expression.               loss function mutations MYBPC1 result distal arthrogry-
    Human contractures distal arthrogryposis hypothesized       posis lethal congenital contracture syndrome type 4, respect- reduced movement utero. demonstrate           ively, establish critical role MYBPC1 embryonic
sociation impaired motor activity curved body phe-         muscle development. studies arthrogryposis notypes mybpc1 morphant zebrafish embryos              gene discovery translational development novel treat-
overexpressing mybpc1-distal arthrogryposis mutations.             ment methods, zebrafish models likely valuable
mybpc1 morphants predominantly ventral body curva-              tools identification disease-modifying pharmaceuticals
ture, zebrafish deficits motor activity       useful new treatments patients congeni- dorsally curved, including zebrafish neb embryos          tal contracture syndromes.
(39), slow muscle-specific actinin-2 morphant (40) mtm1 morphants (41).  absent movement 24 hpf
does itself appear sufficient development         MATERIALS METHODS curved phenotype. example, zebrafish smyhc1 (slow             Zebrafish embryo maintenance
skeletal muscle myosin heavy chain) morphants paralyzed 24 hpf normal straight body phenotype (42). Fur-         Wild-type zebrafish (Danio rerio) maintained embryos
thermore, significance ventral curved zebrafish pheno-      raised described (47). wild-type AB fish type complicated non-specific nature, similar      obtained Zebrafish International Resource Center. Fish
curved shape reported zebrafish models muscu-         anesthetized squeezing using tricaine methanesulfonate
lar dystrophy (43– 45). Future studies needed determine         (3-amino benzoic acidethylester, Sigma) final concentration alterations distal arthrogryposis-associated sar-     0.16  E3 embryo medium (5 mM NaCl, 0.17 mM KCl,
comeric genes, including MYH3, TNNT3, TPM2 TNNI2,                  0.33 mM CaCl2, MgSO4 H2O). animal work approved
result similar embryonic curved phenotypes          animal studies committee Washington University.
motor deficits concordant change body axis.
    human contractures associated 
strained fetal movement (46), wondered pres-            Microinjection MOs mRNA embryos
ence intact chorion contributed highly curved             antisense MOs targeting zebrafish mybpc1 purchased
phenotype observed mybpc1-morphant fish.             Gene Tools, LLC (Philomath,  USA). sequences
taking advantage unique aspects zebrafish development            standard control mybpc1 MOs targeting intron 3–exon 4 removing chorion, showed contracted pheno-         (splice-blocking) ATG start codon (translation-blocking)
type mybpc1 morphants primarily result abnor-        follows: standard control, 5′ -CCTCTTACCTCAG
mal muscle development contribution                TTACAATTTATA-3′ ; splice-blocking MO, 5′ -TATCATCTG
presence intact chorion.                                         AACAGAGACAGAGAGA-3′ ; translation-blocking MO, 5′ -GC
    addition providing tool basic mechanisms      TCAGGCATGTTGAGCCGTTCTCC-3′ . 3′ end standard contracture formation studied, zebrafish model        control splice-blocking MOs modified Lissamine
distal arthrogryposis used quantify deleterious     tag. MOs dissolved nuclease-free water, 1 nl (2 ng)
effects human MYBPC1 gene variants. quantitatively               injected 1- 4-cell-stage embryos.
measuring embryonic motor function response light                 overexpression wild-type mutant zebrafish
stimulus, able distinguish deleterious              mybpc1, coding region zebrafish mybpc1 mRNA human disease causing mutations benign MYBPC1 poly-              cloned pCS2+ multiple expression vector. W220R,
morphism effect motor function.               Y845H H494Q mutant zebrafish mybpc1 constructs mutant RNA injected early development, mutant            generated using QuickChange Site-Directed Mutagenesis Kit
proteins likely expressed muscle, including cardiac,        (Stratagene) according manufacturer’s protocol.
fast slow muscle;  approach likely does         mRNAs synthesized using mMESSAGE mMACHINE
yield fully accurate human disease model.  remains            (Ambion) injected embryos 1 – 4 cell stages.
                                                                       Human Molecular Genetics, 2013, Vol. 22,  24            4975


Reverse transcription –polymerase chain reaction                    Touch-escape response assay measure mRNA expression mybpc1, RNA prepared          Mechanosensory stimuli delivered 3 dpf embryos zebrafish embryos using RNeasy Mini Kit (Qiagen). RNA          insect pins. Embryonic behaviors recorded using reverse transcribed converted complementary            BB FlashBack Express Recorder software (Bluberry Software)
DNA (cDNA) using superscript II Reverse Transcription Kit       dissection microscope (Olympus DP70). Time-lapse
(Invitrogen) according manufacturer’s protocol. Reverse      images embryonic behavior exported using BB
transcription–polymerase chain reaction (RT-PCR)            FlashBack Express Player software (Blueberry Software).
formed using following primers: mybpc1, 5′ -TTTGCC
AAGAGATTGGAACC-3′ 5′ -GATGTGCACTTTGGCA
GAGA-3′ ; EF1a, 5′ -GATGCACCACGAGTCTCTGA-3′                     Western blotting
5′ -TGATGACCTGAGCGTTGAAG-3′ .                                       Embryos dechorionated deyolking buffer (55 mM NaCl,
                                                                    1.8 mM KCl, 1.25 mM NaHCO3) homogenized lysis
                                                                    buffer (20 mM Tris–HCl, pH 7.4, 1  Triton X-100, 150 mM
                                                                    NaCl) complete protease inhibitor cocktail (Roche Applied
Immunofluorescence staining                                         Sciences). Total lysates separated sodium dodecyl immunohistochemistry, embryos 1 2 dpf         sulfate–polyacrylamide gel electrophoresis (SDS–PAGE), dechorionated protease type XIV (Sigma). Embryos            transferred nitrocellulose membrane. Membrane fixed 4  paraformaldehyde (PFA) overnight 48C,              blocked 5  skim milk 1 h incubated anti-Mybpc1
embedded agarose Tissue-Tek O.C.T. medium (Sakura            anti tubulin (DSHB) antibody overnight 48C. Membranes
Finetek USA).  blocks containing embryos          washed 0.1  PBST (0.1  Tween 20 PBS) incu-
frozen liquid nitrogen-chilled methyl butane sectioned.      bated secondary antibody conjugated horseradish perox- sections permeabilized 0.1  Triton X-100, 1           idase 2 h RT. Blots developed chemiluminescent
BSA, 1  DMSO PBS 10 min, blocked blocking               substrate enhanced chemiluminescence (GE Healthcare).
solution (2  normal goat serum PBS) 30 min incu-
bated anti-MYBPC1 (abcam Cat# ab55559), anti-F59  
velopmental Studies Hybridoma Bank) (DSHB) anti-F310             Birefringence assay
(DSHB) antibody blocking solution overnight 48C.        Muscle birefringence analyzed placing anesthetized washes PBS, sections incubated             embryos glass polarizing filter covering AlexaFluor488-conjugated secondary antibody 2 h RT.          second polarizing filter ZEISS AXIOSKOP microscope mount immunofluorescence, embryos placed             (Carl Zeiss). polarizing filter twisted 4  PFA 1 h RT, washed 1  Triton X-100 PBS,          light refracting striated muscle visible (48). permeabilized ice cold acetone 8 min. incubation blocking solution (10  FBS, 1  Triton X-100 PBS) 1 h RT, embryos immunostained anti-Mybpc1 (abcam,          Histology electron microscopy
ab55559), anti-F59 (DSHB) anti-F310 (DSHB), anti-actin           Anesthetized embryos chemically fixed immersion (American Research Products), anti actinin (Sigma) anti-       3  glutaraldehyde 0.1 M cacodylate buffer 3 h. myomesin (DSHB) antibody blocking solution overnight          rinsing cacodylate buffer, fixed 2  osmium
48C.  embryos washed 1  Triton X-100 PBS            tetroxide buffer, rinsed water, dehydrated times incubated AlexaFluor488-conjugated             acetone series embedded Araldite (Ted Pella). light
secondary antibody overnight 48C. Following staining,            microscopy, 0.5– 0.7 mm sections cut stained
embryos imaged using FV1000 confocal microscope                toluidene blue imaged Leica DM2500 microscope
(Olympus).                                                          fitted camera running Leica Application Suite. elec-
                                                                    tron microsopy, sections, 100 nm  cut                                                                     Reichert Ultracut E ultramicrotome, picked uncoated
                                                                    700-mesh hexagonal grids stained uranyl acetate
Measurement spontaneous coiling rate motion index            (1:1, 2  uranyl acetate:ethanol, 30 min) followed Reynolds
Spontaneous coiling rate recorded number events       lead citrate (30 min). imaged Jeol 1200 EX
observed 15 s embryo. Motion index zebrafish         electron microscopy fitted Tietz FastScan CCD camera
embryos measured previously described              running TVIPS software (Tietz). Great care taken distin-
modifications (33). Embryonic behaviors recorded            guishing slow fibers fast fibers. Slow fibers superficial,
30 frames/s using BB FlashBack Express Recorder software            fast fibers deeper. Slow fibers fish run parallel (Bluberry Software) dissecting microscope (Olympus          axis fish fast fibers run parallel myotomes,
DP70). analyze movement embryo, ImageJ soft-         appearance barbed end arrow (49).
ware used convert frame black white image.  software tracked light intensity embryo 30 s. Motion index represents mean absolute         Statistical analysis
value difference light intensity adjacent time    Differences coiling frequency, mean motion index, sur-
points measured 30 times/s embryo. experi-      vival quantified way ANOVA. error bars
ments performed triplicate.                                 shown represent standard error mean.
4976        Human Molecular Genetics, 2013, Vol. 22,  24


SUPPLEMENTARY MATERIAL                                                                 14. Markus, B., Narkis, G., Landau, D., Birk, R , Cohen,  Birk, O.S.
                                                                                           (2012) Autosomal recessive lethal congenital contractural syndrome type 4
Supplementary Material available HMG online.                                         (LCCS4) caused mutation MYBPC1. Hum. Mut., 33, 1435–1438.
                                                                                       15. James, J. Robbins, J. (2011) Signaling myosin-binding protein C.
                                                                                           J. Biol. Chem., 286, 9913–9919.
                                                                                       16. Okagaki, T., Weber, F.E., Fischman, D , Vaughan, K.T., Mikawa, T. ACKNOWLEDGEMENTS                                                                           Reinach, F.C. (1993) major myosin-binding domain skeletal muscle
                                                                                           MyBP-C (C protein) resides COOH-terminal, immunoglobulin C2 work supported grants Shriners Hospital,                          motif. J. Cell Biol., 123, 619–626.
Children’s Discovery Institute Washington University                            17. Freiburg,  Gautel, M. (1996) molecular map interactions
                                                                                           titin myosin-binding protein C. Implications sarcomeric
St. Louis Children’s Hospital. P.K.L. V. acknowledge                             assembly familial hypertrophic cardiomyopathy. Eur. J. Biochem., 235,
support funding British Heart Foundation (RG/11/                               317–323.
21/29335) EC Grant Agreement n. 241577 (BIG-Heart)                                 18. Gruen, M. Gautel, M. (1999) Mutations beta-myosin S2 cause
FP7 Seventh Framework Programme Health. Zebrafish Inter-                               familial hypertrophic cardiomyopathy (FHC) abolish interaction
national Resource Center supported grant P40 RR012546                                regulatory domain myosin-binding protein-C. J. Mol. Biol., 286,
                                                                                           933–949. NIH-NCRR. thank Dr Lila Solnica-Krezel                                 19. Moos, C., Mason, C.M., Besterman, J.M., Feng, N. Dubin, J.H. (1978)
Kelly Monk reviewing manuscript Doug Oppedal                                   binding skeletal muscle C-protein F-actin, relation help maintaining zebrafish.                                                    interaction actin myosin subfragment-1. J. Mol. Biol., 124, 571–586.
                                                                                       20. Oakley, C.E., Chamoun, J., Brown, L.J. Hambly, B.D. (2007) Myosin
Conflict statement. declared.                                             binding protein-C: enigmatic regulator cardiac contraction.
                                                                                           Int. J. Biochem. Cell Biol., 39, 2161–2166.
                                                                                       21. Ackermann, M  Kontrogianni-Konstantopoulos,  (2011) Myosin
                                                                                           binding protein-C slow novel substrate protein kinase (PKA) C
                                                                                           (PKC) skeletal muscle. J. Proteome Res., 10, 4547– 4555.
REFERENCES                                                                             22. Chen, , Zhao, T.J., Li, J., Gao, Y.S., Meng, F.G., Yan, Y.B. Zhou, H.M.
 1. Bamshad, M., Van Heest, E. Pleasure, D. (2009) Arthrogryposis:                 (2011) Slow skeletal muscle myosin-binding protein-C (MyBPC1) mediates
    review update. J. Bone Joint Surg. , 91, 40– 46.                                recruitment muscle-type creatine kinase (CK) myosin. Biochem. J.,
 2. Hall, J.G. (1985) Genetic aspects arthrogryposis. Clin. Ortho. Relat. Res.,         436, 437– 445.
    194, 44– 53.                                                                       23. Colson, B , Rybakova, N., Prochniewicz, E., Moss, R.L. Thomas,
 3. Toydemir, R.M., Rutherford, , Whitby, F.G., Jorde, L.B., Carey, J.C.             D.D. (2012) Cardiac myosin binding protein-C restricts intrafilament
    Bamshad, M.J. (2006) Mutations embryonic myosin heavy chain (MYH3)                  torsional dynamics actin phosphorylation-dependent manner. Proc.
    cause Freeman-Sheldon syndrome Sheldon-Hall syndrome. Nat. Genet.,                 Natl Acad. Sci. USA, 109, 20437–20442.
    38, 561– 565.                                                                      24. Barefield, D. Sadayappan, S. (2010) Phosphorylation function  4. Tajsharghi, H., Kimber, E., Holmgren, D., Tulinius, M. Oldfors,                  cardiac myosin binding protein-C health disease. J. Mol. Cell.
    (2007) Distal arthrogryposis muscle weakness associated                     Cardiol., 48, 866–875.
    beta-tropomyosin mutation. Neurology, 68, 772 –775.                                25. Marston, S., Copeland, O., Gehmlich, K., Schlossarek, S. Carrier, L.
 5. Sung, S.S., Brassington, M., Grannatt, K., Rutherford, , Whitby, F.G.,             (2012) MYBPC3 mutations cause hypertrophic cardiomyopathy?
    Krakowiak, P , Jorde, L.B., Carey, J.C. Bamshad, M. (2003)                       J. Muscle Res. Cell Motil., 33, 75–80.
    Mutations genes encoding fast-twitch contractile proteins cause distal          26. Marston, S., Copeland, O., Jacques, , Livesey, K., Tsang, V., McKenna,
    arthrogryposis syndromes.  J. Hum. Genet., 72, 681–690.                             W.J., Jalilzadeh, S., Carballo, S., Redwood, C. Watkins, H. (2009)
 6. Sung, S.S., Brassington, M., Krakowiak, P , Carey, J.C., Jorde, L.B.           Evidence human myectomy samples MYBPC3 mutations cause
    Bamshad, M. (2003) Mutations TNNT3 cause multiple congenital                        hypertrophic cardiomyopathy haploinsufficiency. Circ. Res., 105,
    contractures: second locus distal arthrogryposis type 2B.  J. Hum.            219–222.
    Genet., 73, 212– 214.                                                              27. van Dijk, S.J., Dooijes, D., dos Remedios, C., Michels, M., Lamers, J.M.,
 7. Gurnett, C , Desruisseau, D.M., McCall, K., Choi, R., Meyer, ,                   Winegrad, S., Schlossarek, S., Carrier, L., Cate, F.J., Stienen, G.J. et al.
    Talerico, M., Miller, S.E., Ju, J.S., Pestronk, , Connolly, M. et al. (2010)       (2009) Cardiac myosin-binding protein C mutations hypertrophic
    Myosin binding protein C1: novel gene autosomal dominant distal                  cardiomyopathy: haploinsufficiency, deranged phosphorylation,     arthrogryposis type 1. Hum. Mol. Genet., 19, 1165–1173.                                cardiomyocyte dysfunction. Circulation, 119, 1473–1483.
 8. Beck, E., McMillin, M.J., Gildersleeve, H , Kezele, P.R., Shively, K.M.,       28. Xu, Y.,  J., Wang, X., Lim, T.M. Gong,  (2000) Asynchronous
    Carey, J.C., Regnier, M. Bamshad, M.J. (2013) Spectrum mutations                activation 10 muscle-specific protein (MSP) genes zebrafish
    cause distal arthrogryposis types 1 2B.  J. Med. Genet.  161,            somitogenesis. Dev. Dyn., 219, 201 –215.
    550– 555.                                                                          29. Miller, J.B., Teal, S.B. Stockdale, F.E. (1989) Evolutionarily conserved
 9. Offer, G., Moos, C. Starr, R. (1973) new protein filaments          sequences striated muscle myosin heavy chain isoforms. Epitope mapping
    vertebrate skeletal myofibrils. Extractions, purification                       cDNA expression. J. Biol. Chem., 264, 13122–13130.
    characterization. J. Mol. Biol., 74, 653– 676.                                     30. Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B. Schilling,
10. Gautel, M., Zuffardi, O., Freiburg,  Labeit, S. (1995) Phosphorylation           T.F. (1995) Stages embryonic development zebrafish. Dev. Dyn.,
    switches specific cardiac isoform myosin binding protein-C:               203, 253– 310.
    modulator cardiac contraction? EMBO J., 14, 1952– 1960.                         31. Saint-Amant, L. Drapeau, P. (1998) Time course development 11. Weber, F.E., Vaughan, K.T., Reinach, F.C. Fischman, D  (1993)                    motor behaviors zebrafish embryo. J. Neurobiol., 37, 622–632.
    Complete sequence human fast-type slow-type muscle                          32. Naganawa, Y. Hirata, H. (2011) Developmental transition touch
    myosin-binding-protein C (MyBP-C). Differential expression, conserved                  response slow muscle-mediated coilings fast muscle-mediated burst
    domain structure chromosome assignment. Eur. J. Biochem., 216,                     swimming zebrafish. Dev. Biol., 355, 194 –204.
    661– 669.                                                                          33. Kokel, D., Bryan, J., Laggner, C., White, R., Cheung, C.Y., Mateus, R.,
12. Bonne, G., Carrier, L., Bercovici, J., Cruaud, C., Richard, P., Hainque, B.,           Healey, D., Kim, S., Werdich, , Haggarty, S.J. et al. (2010) Rapid
    Gautel, M., Labeit, S., James, M., Beckmann, J. et al. (1995) Cardiac myosin           behavior-based identification neuroactive small molecules     binding protein-C gene splice acceptor site mutation associated                zebrafish. Nat. Chem. Biol., 6, 231–237.
    familial hypertrophic cardiomyopathy. Nat. Genet., 11, 438– 440.                   34. Dhoot, G.K. Perry, S.V. (2005) Expression slow skeletal myosin
13. Watkins, H., Conner, D., Thierfelder, L., Jarcho, J , MacRae, C.,                    binding C-protein normal adult mammalian heart. J. Muscle Res. Cell
    McKenna, W.J., Maron, B.J., Seidman, J.G. Seidman, C.E. (1995)                     Motil., 26, 143– 148.
    Mutations cardiac myosin binding protein-C gene chromosome 11            35. Ackermann, M , Patel, P.D., Valenti, J., Takagi, Y., Homsher, E., Sellers,
    cause familial hypertrophic cardiomyopathy. Nat. Genet., 11, 434– 437.                 J.R. Kontrogianni-Konstantopoulos,  (2013) Loss actomyosin
                                                                                             Human Molecular Genetics, 2013, Vol. 22,  24                         4977


      regulation distal arthrogryposis myopathy mutant myosin binding          42. Codina, M., Li, J., Gutierrez, J., Kao, J.P. Du, S.J. (2010) Loss Smyhc1
      protein-C slow. FASEB J., 27, doi:10.1096/fj.13-228882.                                Hsp90alpha1 function results different effects myofibril
36.   Carrier, L., Bonne, G., Bahrend, E., Yu, B., Richard, P., Niel, F., Hainque, B.,       organization skeletal muscles zebrafish embryos. PLoS  5, e8416.
      Cruaud, C., Gary, F., Labeit, S. et al. (1997) Organization sequence        43. Guyon, J.R., Mosley, N., Zhou, Y., O’Brien, K.F., Sheng, X., Chiang, K.,
      human cardiac myosin binding protein C gene (MYBPC3) identification                Davidson, J., Volinski, J.M., Zon, L  Kunkel, L.M. (2003)       mutations predicted produce truncated proteins familial hypertrophic          dystrophin associated protein complex zebrafish. Hum. Mol. Genet., 12,
      cardiomyopathy. Circ. Res., 80, 427 –434.                                              601– 615.
37.   Gautel, M., Furst, D.O., Cocco,  Schiaffino, S. (1998) Isoform               44. Zhang, R., Yang, J., Zhu, J. Xu, X. (2009) Depletion zebrafish
      transitions myosin binding protein C family developing human             Tcap leads muscular dystrophy disrupting sarcomere-membrane
      mouse muscles: lack isoform transcomplementation cardiac muscle.                 interaction, sarcomere assembly. Hum. Mol. Genet., 18,
      Circ. Res., 82, 124–129.                                                               4130–4140.
38.   Harris, S.P., Bartley, C.R., Hacker, T , McDonald, K.S., Douglas, P.S.,          45. Telfer, W.R., Busta, S., Bonnemann, C.G., Feldman, E.L. Dowling,
      Greaser, M.L., Powers, P  Moss, R.L. (2002) Hypertrophic                         J.J. (2010) Zebrafish models collagen VI-related myopathies. Hum. Mol.
      cardiomyopathy cardiac myosin binding protein-C knockout mice. Circ.                Genet., 19, 243